Daniel R. Gomez, MD, MBA, has been named chair of the Department of Radiation Oncology at NYU Grossman School of Medicine. Dr. Gomez joins NYU Langone from Memorial Sloan Kettering Cancer Center, where he was an attending physician, the director of thoracic radiation oncology, and vice chair of clinical operations in the Department of Radiation Oncology.

As department chair, Dr. Gomez will lead multidisciplinary teams of investigators and physicians to deliver world-class research and innovative care to patients being treated across the spectrum of cancer, both with respect to novel indications for radiation therapy and in personalizing the radiation approach based on clinical, imaging, and molecular characteristics.

“Dr. Gomez is an exceptional physician and researcher who is passionate about bringing research insights into his care of patients,” said Oren Cahlon, MD, executive vice president and vice dean for clinical affairs and strategy, chief clinical officer, at NYU Langone. “His proven leadership skills and experience in the field of radiation therapy makes him a key part of our commitment to offering the best outcomes for our patients.”

Dr. Gomez has specialized experience in using radiation therapy for the treatment of oligometastatic cancers, an intermediate subclass of stage 4 cancer in which the disease has spread to or progressed in more limited sites. This disease state represents a middle ground between localized and widespread metastatic disease, and management is complex and involves collaboration between radiation oncology and multiple other disciplines. Dr. Gomez has extensive clinical experience in this area and has also led many clinical trials and translational analyses.

“I am very honored to join NYU Langone Perlmutter Cancer Center,” said Dr. Gomez. “There is an incredible amount of energy and enthusiasm throughout the medical center, which is inspiring in the mission to improve cancer care for our patients. In addition, the Department of Radiation Oncology at NYU Langone consists of compassionate and talented physicians and researchers dedicated to delivering treatment that is of the highest quality, innovative, and individualized to each patient. I am thrilled to join this team.”

About Dr. Gomez

Dr. Gomez is a radiation oncologist whose academic path spans economics, medicine, and business. He earned a bachelor’s degree in economics from the University of Virginia and an MD from the University of California, San Francisco, followed by a radiation oncology residency at Memorial Sloan Kettering Cancer Center. He completed a Doris Duke Clinical Research Fellowship at Columbia University, later earned an MBA from Rice University, and underwent additional training specifically pertaining to the use of AI in healthcare.

Professionally, Dr. Gomez has worked at The University of Texas MD Anderson Cancer Center, rising to associate professor and holding leadership posts in radiation that included thoracic radiation oncology section chief and clinical medical director. He subsequently joined Memorial Sloan Kettering Cancer Center, where he served as Manhattan service chief, director of thoracic radiation oncology, and vice chair of clinical operations in the department. He also served as an officer of the hospital medical staff, among other institutional leadership roles.

Dr. Gomez’s research centers on lung cancer and the role of radiation therapy in oligometastatic disease, with a portfolio spanning biomarker-integrated local ablative strategies, minimal residual disease, and consolidation approaches with targeted and immunotherapies. He has led or co-led many investigator-initiated studies, industry- and cooperative group–funded trials, trials involving ctDNA-defined residual disease, and the evaluation of radiation with immunotherapy combinations; he was also co–principal investigator of NRG-LU002, the largest randomized trial to date evaluating local consolidative therapy in oligometastatic non-small cell lung cancer.

His bibliography includes extensive peer-reviewed publications and invited lectures worldwide, alongside service on editorial boards, national guideline committees, and the American Board of Radiology oral boards, underscoring his impact on clinical practice standards and trial design in thoracic oncology.

About NYU Langone Health

NYU Langone Health is a fully integrated health system that consistently achieves the best patient outcomes through a rigorous focus on quality that has resulted in some of the lowest mortality rates in the nation. Vizient Inc. has ranked NYU Langone No. 1 out of 118 comprehensive academic medical centers across the nation for four years in a row, and U.S. News & World Report recently ranked four of its clinical specialties No. 1 in the nation. NYU Langone offers a comprehensive range of medical services with one high standard of care across seven inpatient locations, its Perlmutter Cancer Center, and more than 320 outpatient locations in the New York area and Florida. The system also includes two tuition-free medical schools, in Manhattan and on Long Island, and a vast research enterprise.

Media Inquiries

Ryan Dziuba
Phone: 212-404-4131
Ryan.Dziuba@NYULangone.org